{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:42:01Z","timestamp":1789785721735,"version":"4.0.1"},"reference-count":72,"publisher":"Frontiers Media SA","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/tri.12706","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T07:28:57Z","timestamp":1445066937000},"page":"392-402","source":"Crossref","is-referenced-by-count":32,"title":["Complement inhibition as potential new therapy for antibody-mediated rejection"],"prefix":"10.3389","volume":"29","author":[{"given":"Farsad","family":"Eskandary","sequence":"first","affiliation":[{"name":"Division of Nephrology and Dialysis; Department of Medicine III; Medical University Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wahrmann","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis; Department of Medicine III; Medical University Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"M\u00fchlbacher","sequence":"additional","affiliation":[{"name":"Department of Surgery; Medical University Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis; Department of Medicine III; Medical University Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"10.1111\/tri.12706-BIB0001|tri12706-cit-0001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0002|tri12706-cit-0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0003|tri12706-cit-0003","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1681\/ASN.2014060588","article-title":"Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients","volume":"26","author":"Halloran","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12706-BIB0004|tri12706-cit-0004","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1432-2277.2011.01309.x","article-title":"Prevention and treatment of alloantibody-mediated kidney transplant rejection","volume":"24","author":"Bartel","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12706-BIB0005|tri12706-cit-0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1432-2277.2012.01453.x","article-title":"Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale","volume":"25","author":"Fehr","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12706-BIB0006|tri12706-cit-0006","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0007|tri12706-cit-0007","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0008|tri12706-cit-0008","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ki.2011.502","article-title":"Proteasome inhibitor-based therapy for antibody-mediated rejection","volume":"81","author":"Walsh","year":"2012","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12706-BIB0009|tri12706-cit-0009","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/TP.0b013e31825d1587","article-title":"The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review","volume":"94","author":"Roberts","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.12706-BIB0010|tri12706-cit-0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0011|tri12706-cit-0011","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1600-6143.2010.03226.x","article-title":"Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation","volume":"10","author":"Bartel","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0012|tri12706-cit-0012","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0013|tri12706-cit-0013","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2012.01447.x","article-title":"Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12706-BIB0014|tri12706-cit-0014","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0015|tri12706-cit-0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0016|tri12706-cit-0016","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0000000000000188","article-title":"Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation","volume":"98","author":"Bentall","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.12706-BIB0017|tri12706-cit-0017","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/tri.12706-BIB0018|tri12706-cit-0018","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOT.0000000000000037","article-title":"Mechanisms of rejection: role of complement","volume":"19","author":"Farrar","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/tri.12706-BIB0019|tri12706-cit-0019","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","article-title":"Eculizumab for paroxysmal nocturnal haemoglobinuria","volume":"373","author":"Parker","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/tri.12706-BIB0020|tri12706-cit-0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/tri.12706-BIB0021|tri12706-cit-0021","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri3761","article-title":"Complement-tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/tri.12706-BIB0022|tri12706-cit-0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0023|tri12706-cit-0023","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/ki.1993.187","article-title":"Capillary deposition of C4d complement fragment and early renal graft loss","volume":"43","author":"Feucht","year":"1993","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12706-BIB0024|tri12706-cit-0024","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V1341091","article-title":"Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury","volume":"13","author":"B\u00f6hmig","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12706-BIB0025|tri12706-cit-0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00041552-200211000-00007","article-title":"Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment","volume":"11","author":"Mauiyyedi","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/tri.12706-BIB0026|tri12706-cit-0026","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/01.ASN.0000025780.03790.0F","article-title":"Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection","volume":"13","author":"Regele","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12706-BIB0027|tri12706-cit-0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2014.166","article-title":"A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection","volume":"87","author":"Sapir-Pichhadze","year":"2014","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12706-BIB0028|tri12706-cit-0028","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2215\/CJN.09901014","article-title":"Capillary C4d and kidney allograft outcome in relation to morphologic lesions suggestive of antibody-mediated rejection","volume":"10","author":"Kikic","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12706-BIB0029|tri12706-cit-0029","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0030|tri12706-cit-0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12706-BIB0031|tri12706-cit-0031","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.4049\/jimmunol.179.7.4451","article-title":"Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/tri.12706-BIB0032|tri12706-cit-0032","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0033|tri12706-cit-0033","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","article-title":"Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0034|tri12706-cit-0034","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOT.0b013e32835d4daf","article-title":"Pathology of C4d-negative antibody-mediated rejection in renal allografts","volume":"18","author":"Haas","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/tri.12706-BIB0035|tri12706-cit-0035","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1600-6143.2008.02295.x","article-title":"The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy","volume":"8","author":"Csencsits","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0036|tri12706-cit-0036","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-6143.2009.02958.x","article-title":"Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice","volume":"10","author":"Hirohashi","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0037|tri12706-cit-0037","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0038|tri12706-cit-0038","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1600-6143.2006.01356.x","article-title":"C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings","volume":"6","author":"Haas","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0039|tri12706-cit-0039","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2008030279","article-title":"C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts","volume":"20","author":"Haas","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12706-BIB0040|tri12706-cit-0040","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1111\/tri.12706-BIB0041|tri12706-cit-0041","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2014-03-560540","article-title":"Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"125","author":"Peffault de Latour","year":"2015","journal-title":"Blood"},{"key":"10.1111\/tri.12706-BIB0042|tri12706-cit-0042","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0043|tri12706-cit-0043","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0044|tri12706-cit-0044","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/tri.12396","article-title":"Antibody-mediated rejection despite inhibition of terminal complement","volume":"27","author":"Bentall","year":"2014","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12706-BIB0045|tri12706-cit-0045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","article-title":"Infections of people with complement deficiencies and patients who have undergone splenectomy","volume":"23","author":"Ram","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/tri.12706-BIB0046|tri12706-cit-0046","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"key":"10.1111\/tri.12706-BIB0047|tri12706-cit-0047","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1111\/tri.12706-BIB0048|tri12706-cit-0048","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0049|tri12706-cit-0049","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ajt.12032","article-title":"Meningococcal sepsis complicating eculizumab treatment despite prior vaccination","volume":"13","author":"Struijk","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0050|tri12706-cit-0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0051|tri12706-cit-0051","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"key":"10.1111\/tri.12706-BIB0052|tri12706-cit-0052","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12706-BIB0053|tri12706-cit-0053","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0054|tri12706-cit-0054","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0055|tri12706-cit-0055","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/j.1600-6143.2010.03191.x","article-title":"Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access","volume":"10","author":"Lonze","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0056|tri12706-cit-0056","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/j.1432-2277.2011.01290.x","article-title":"Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation","volume":"24","author":"Biglarnia","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12706-BIB0057|tri12706-cit-0057","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.transproceed.2012.03.053","article-title":"Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant","volume":"44","author":"Stewart","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12706-BIB0058|tri12706-cit-0058","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.transproceed.2012.09.038","article-title":"Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports","volume":"44","author":"Gonzalez-Roncero","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12706-BIB0059|tri12706-cit-0059","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1600-6143.2012.04124.x","article-title":"Antibody mediated rejection associated with complement factor h-related protein 3\/1 deficiency successfully treated with eculizumab","volume":"12","author":"Noone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0060|tri12706-cit-0060","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.transproceed.2013.02.062","article-title":"Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports","volume":"45","author":"Kocak","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12706-BIB0061|tri12706-cit-0061","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/petr.12187","article-title":"Plasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody","volume":"18","author":"Ghirardo","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1111\/tri.12706-BIB0062|tri12706-cit-0062","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/TP.0000000000000184","article-title":"Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts","volume":"98","author":"Burbach","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.12706-BIB0063|tri12706-cit-0063","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1542\/peds.2014-2275","article-title":"Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient","volume":"135","author":"Chehade","year":"2015","journal-title":"Pediatrics"},{"key":"10.1111\/tri.12706-BIB0064|tri12706-cit-0064","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.healun.2012.09.016","article-title":"Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab","volume":"31","author":"Dawson","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.12706-BIB0065|tri12706-cit-0065","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/ajt.13183","article-title":"Eculizumab Salvage Therapy for Antibody-Mediated Rejection in a Desensitization-Resistant Intestinal Re-Transplant Patient","volume":"15","author":"Fan","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0066|tri12706-cit-0066","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/ajt.12715","article-title":"The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant","volume":"14","author":"Chandraker","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0067|tri12706-cit-0067","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/TP.0000000000000298","article-title":"Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation","volume":"98","author":"Orandi","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.12706-BIB0068|tri12706-cit-0068","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.12706-BIB0069|tri12706-cit-0069","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/ajt.13273","article-title":"An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA","volume":"15","author":"Thomas","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12706-BIB0070|tri12706-cit-0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gft502","article-title":"ABO antibody and complement depletion by immunoadsorption combined with membrane filtration-a randomized, controlled, cross-over trial","volume":"29","author":"Eskandary","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12706-BIB0071|tri12706-cit-0071","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21399","article-title":"Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation-Results of a randomized controlled crossover study","author":"Biesenbach","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1111\/tri.12706-BIB0072|tri12706-cit-0072","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1745-6215-15-107","article-title":"Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial","volume":"15","author":"Eskandary","year":"2014","journal-title":"Trials"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12706","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12706\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T12:57:01Z","timestamp":1653310621000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12706","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}